CMPX Compass Therapeutics Inc Com

  0%
Previous Close
Open
52 Week Low
52 Week High
Market Cap $0
Shares 61,120,062
Float 35,139,675
Enterprise Value $0
Volume 0
Av. Daily Volume 0
Stock charts supplied by TradingView

Upcoming Catalysts

Drug Stage Catalyst Date
CTX-471
Solid Tumors
Phase 1
Phase 1
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.
CTX-471 and trastuzumab (Herceptin)
EGFR positive tumors
Phase 1
Phase 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien.